Edition:
United Kingdom

LeMaitre Vascular Inc (LMAT.OQ)

LMAT.OQ on NASDAQ Stock Exchange Global Market

32.26USD
11 Dec 2017
Change (% chg)

$0.57 (+1.80%)
Prev Close
$31.69
Open
$31.70
Day's High
$32.27
Day's Low
$31.67
Volume
41,278
Avg. Vol
65,047
52-wk High
$39.88
52-wk Low
$19.83

Latest Key Developments (Source: Significant Developments)

Lemaitre Vascular sees ‍Q4 sales of $25.8 mln
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Lemaitre Vascular Inc :Lemaitre Vascular Inc - qtrly earnings per share ‍$0.25​.Lemaitre Vascular Inc - qtrly ‍sales of $24.8 million, up 7% from Q3 2016​.Lemaitre Vascular Inc - sees ‍Q4 2017 sales of$25.8 million​.Lemaitre Vascular Inc - sees ‍Q4 EPS in range of $0.19 to $0.21​.Lemaitre Vascular Inc - sees ‍full year 2017 EPS in range of $0.83 to $0.85​.  Full Article

Lemaitre Vascular says Q2 earnings per share $0.14
Wednesday, 27 Jul 2016 

Lemaitre Vascular Inc : Lemaitre q2 2016 record sales $22.4mm (+13%), record op. Income $3.8mm (+35%) . Q2 earnings per share $0.14 . Q2 earnings per share view $0.11 -- Thomson Reuters I/B/E/S .Lemaitre vascular inc qtrly sales of $22.4 million, up 13 percent.  Full Article

LeMaitre Vascular, Inc gives Q2 2016 guidance; raises FY 2016 guidance
Monday, 2 May 2016 

LeMaitre Vascular, Inc:Expects Q2 2016 sales of $21.6 mln, a reported increase of 9% vs. Q2 2015.expects Q2 2016 gross margin of 69.0%.expects Q2 2016 operating income of $3.2 mln (15% operating margin), an increase of 15% vs. Q2 2015.Increased FY 2016 sales guidance to $85.7 mln, a reported increase of 9% vs. 2015.expects FY 2016 gross margin of 70.5%.increased FY 2016 operating income guidance to $14.3 mln (17% operating margin), a 24% increase vs. 2015.  Full Article

LeMaitre Vascular acquires ProCol Vascular Bioprosthesis
Friday, 18 Mar 2016 

LeMaitre Vascular:Has acquired the ProCol Vascular Bioprosthesis product line from Hancock Jaffe Laboratories Inc for $665,000 plus a three year royalty.In conjunction with the acquisition, Hancock Jaffe Laboratories will provide manufacturing transition services to LeMaitre Vascular from its production facility in Irvine, CA for up to five years.  Full Article

BRIEF-Lemaitre Vascular sees ‍Q4 sales of $25.8 mln

* Lemaitre Vascular Inc - qtrly ‍sales of $24.8 million, up 7% from Q3 2016​